Werbung ausblenden

News zu Innate Pharma

Number of Shares and Voting Rights of Innate Pharma as of March 1, 2022 · Uhr · Business Wire
Number of Shares and Voting Rights of Innate Pharma as of February 1, 2022 · Uhr · Business Wire
Innate Pharma to Participate in Upcoming Investor Conferences · Uhr · Business Wire
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2022 · Uhr · Business Wire
Innate Pharma Obtains €28.7m in Non-Dilutive Financing in the Form of State Guaranteed Loans · Uhr · Business Wire
Innate Pharma to Participate in Upcoming Investor Conferences · Uhr · Business Wire
Innate Pharma: Monalizumab Combined With Cetuximab and Durvalumab Demonstrates Anti-Tumor Activity in First-Line Recurrent or Metastatic Head and Neck Cancer at ESMO Immuno-Oncology 2021 Congress · Uhr · Business Wire
Innate Pharma to Participate in the Evercore ISI 4th Annual HealthConX Virtual Conference · Uhr · Business Wire
Innate Pharma Third Quarter 2021 Report · Uhr · Business Wire
Innate Pharma Highlights New NK Cell Engager Data With Partner Sanofi at SITC Annual Meeting · Uhr · Business Wire
Innate Pharma Announces Conference Call and Webcast for Q3 2021 Business Update · Uhr · Business Wire
Innate Pharma 2022 Financial Calendar · Uhr · Business Wire